Filing Details
- Accession Number:
- 0001209191-22-027164
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-05-04 17:17:43
- Reporting Period:
- 2022-05-03
- Accepted Time:
- 2022-05-04 17:17:43
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
708818 | Nextgen Healthcare Inc. | NXGN | Services-Computer Integrated Systems Design (7373) | 952888568 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1664295 | A David Metcalfe | 3525 Piedmont Rd., Ne Building 6, Suite 700 Atlanta GA 30305 | Chief Technology Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-05-03 | 16,162 | $14.20 | 171,175 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2022-05-03 | 17,676 | $14.07 | 188,851 | No | 4 | M | Direct | |
Common Stock | Disposition | 2022-05-03 | 33,838 | $20.00 | 155,013 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2022-05-03 | 16,162 | $0.00 | 16,162 | $14.20 |
Common Stock | Stock Option (right to buy) | Disposition | 2022-05-03 | 17,676 | $0.00 | 17,676 | $14.07 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
150,000 | 2024-02-01 | No | 4 | M | Direct | |
122,324 | 2025-10-31 | No | 4 | M | Direct |
Footnotes
- Pursuant to a 10b5-1(c) plan adopted by the reporting person on March 15, 2022.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to$20.085. Full information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or its stockholdersupon request.
- Original grant of 200,000 options granted on 2/1/2016 vested in four equal, annual installments beginning 2/1/2017.
- Original grant of 140,000 options granted on 10/31/2017 vested in four equal, annual installments beginning 10/31/2018.